Who checks my label before it becomes a problem, and can I trust whoever does it?

This reads United States federal rules, and the three parts it reads do not treat the three product classes alike. Say which one you are before you read the rest.

For a dietary supplement, 21 CFR part 111 defines examinations and tests and names what each is measured against. Most of this article is about those. For a conventional food, the panel accuracy provisions of part 101 apply and the part 111 clauses do not. For a cosmetic, part 701 is a labeling part: it sets out what a label must carry and when a shipment is exempt, and searching every clause of it, it defines no examination or test of the kind part 111 defines. So for a cosmetic, the answer to who checks the label, in that part, is nobody. Over-the-counter drug labels run through a different part and are not read here. If your product does something a drug does, none of these three parts is the whole answer for you, and the prior question is which category you are in at all, which is where our article on whether a product is a cosmetic, a drug, a supplement or a food starts.

Method for that cosmetics finding: a full-text search of every clause of 21 CFR part 701, read on August 20, 2026, for an examination, test or verification duty, then a reading of each hit. The only hits are the words examined and examine inside the definition of a principal display panel (701.10), which describes how a package is looked at on a shelf. What this does not evidence: it is a search of one part, and a duty could sit in an authority not read here.

Then the applicability limits inside the supplement material, because they take a lot of readers out of it. You are subject to the supplement manufacturing part if you manufacture, package, label or hold a dietary supplement (21 CFR 111.1(a)). The part’s one carve-out removes the holding requirements where you hold supplements at a retail establishment for the sole purpose of direct retail sale to individual consumers. It then tells you where the edge of that carve-out is: a retail establishment does not include a warehouse or other storage facility for a retailer, and does not include one that sells directly to consumers (111.1(b)).

So a brand owner who does none of those four things is not brought in by that sentence, and every clause below carrying a 111 number is addressed to somebody else. That does not put your product outside these checks. It puts you outside the duty. Your maker is the addressee, the checks below are the ones your product actually passed through, and reading them is how you know what to ask for and what an answer is worth.

The Supplement Facts panel then carries three exemptions of its own: a small retailer selling direct to consumers under the sales thresholds (101.36(h)(1)); a low-volume product where the exemption is claimed and filed before the beginning of the period it covers, by a person who meets the clause’s own test for average full-time equivalent employees (101.36(h)(2); 101.9(j)(18)); and product shipped in bulk that is not for distribution to consumers in that form and is for use solely in making other supplements, or is to be processed, labeled or repacked at another site (101.36(h)(3)). The first two are conditional on your labels, labeling and advertising carrying no nutrition information and no nutrient content or health claim — a nutrient content claim being one that expressly or implicitly characterizes the level of a nutrient of the type required to be in nutrition labeling (101.13(b); 101.13(a)). Where any of the three exemptions reaches you, the accuracy test described below is not the test you are measured by. And a shipment of a cosmetic that is, in accordance with the practice of the trade, to be processed, labeled or repacked in substantial quantity at an establishment other than the one that originally processed or packed it is exempt from compliance with the labeling requirements of two named sections of the Act, while it moves in interstate commerce and while it is held at that establishment, on the conditions the clause then sets out (21 CFR 701.9(a); 701.9(b); 701.9(c)).

On this page: The checks these parts actually define · Every defined check names its own benchmark · What a laboratory is actually asked · What a supplier’s certificate is evidence of · The accuracy test you are measured by is not the one you ran · Which check answers which question · The checks no rule defines · What passes every check · Four things to check before your next print run

The checks these parts actually define

Three, and only one of them is a gate.

The gate is the health claim. No expressed or implied health claim may be made on the label or in the labeling of a food, whether it is in conventional food form or in dietary supplement form, unless the claim is specifically provided for in the subpart that carries the authorized ones (21 CFR 101.14(e); 101.14(e)(1)). FDA promulgates a regulation authorizing one only when it determines, on the totality of publicly available scientific evidence, that there is significant scientific agreement among experts qualified by scientific training and experience to evaluate such claims that the claim is supported by that evidence (101.14(c)). Any interested person may petition for such a regulation (101.70(a)), and the agency writes back within 100 days to say the petition has been filed for comprehensive review or denied (101.70(j)(2)), then again within 90 days of filing (101.70(j)(3)). A defined reviewer, a named benchmark, a real consequence. It reaches one narrow class of wording and nothing else on your pack.

The second is a notification rather than a clearance, and it covers a much more common kind of sentence. Where a supplement bears a structure and function statement, the manufacturer, packer or distributor must notify FDA no later than 30 days after the first marketing of the product with that statement on it (21 CFR 101.93(a)(1)). To know whether a line on your pack is one, read the statute’s own description: a statement that describes the role of a nutrient or dietary ingredient intended to affect the structure or function in humans, characterizes the documented mechanism by which it acts to maintain that structure or function, describes general well-being from consuming it, or claims a benefit related to a classical nutrient deficiency disease while disclosing the prevalence of that disease in the United States (21 U.S.C. 343(r)(6)(A)). The clause sets an outer deadline and no answer comes back. Nothing in it turns the notice into a permission.

The third is also a notification, and it is about an ingredient rather than a label. A new dietary ingredient is one that was not marketed in the United States before October 15, 1994 (21 U.S.C. 350b(d)), and a supplement containing one is deemed adulterated unless it meets one of two requirements (350b(a)). Either the supplement contains only dietary ingredients that have been present in the food supply as an article used for food, in a form in which the food has not been chemically altered (350b(a)(1)); or there is a history of use or other evidence of safety establishing that the ingredient, used under the conditions recommended or suggested in the labeling, will reasonably be expected to be safe, and at least 75 days before being introduced or delivered for introduction into interstate commerce the manufacturer or distributor provides the Secretary with information, including any citation to published articles, which is the basis on which it concluded that (350b(a)(2)). Read whose conclusion that is. It is the submitter’s, and its subject is the ingredient’s safety rather than the words on the panel.

One thing that is not a check at all, and gets read as one. The statute requires the Secretary to make any facility engaged in manufacturing, processing, packing or holding food for consumption in the United States register with the Secretary (350d(a)(1)). Registration is registration. There is nothing in it that reads a label and nothing in it that approves anything, and a facility being registered says nothing about your artwork.

Outside those three, nobody stands between your artwork and your customer unless you put them there. That is the easy half of the answer and not the useful one. The useful half is what the people you do put there are able to see.

Every defined check names its own benchmark

Start with the check most people already assume is the check. The examinations in the supplement rule that touch a label each name a document to measure against, and there are two of them.

Before you use labels, you must at a minimum conduct a visual examination of the label and review the supplier’s invoice, guarantee or certification, to determine whether label specifications are met (21 CFR 111.75(f)(2)). A label specification is a document you were required to establish yourself (111.70(d)). On the finished pack you must at a minimum conduct a visual examination of the packaging and labeling of the finished packaged and labeled supplements, to determine whether you used the specified packaging and applied the specified label (111.75(g)), against specifications you also had to establish (111.70(g)). And before packaging and labeling operations, packaging and labels for each batch are examined to determine whether they conform to the master manufacturing record (111.410(c)) — the written record you must prepare and follow for each unique formulation and each batch size (111.205(a)), which has to include a description of the packaging and a representative label, or a cross-reference to where the actual or representative label is held (111.210(g)).

Our article on who is supposed to build the label content works through what that chain settles and what it leaves open, and there is no point repeating it here. What matters for this question is the shape of it. Two benchmarks, and both of them are documents of yours: a specification you wrote, and a master record you filed a label into.

Hold on to that shape, because it repeats. Every check a rule defines works this way. The benchmarks are different each time, and that difference is the answer to the question you came with.

What a laboratory is actually asked

A laboratory does not read your label. It measures material against a number, and the number came from you.

The rule that puts finished-batch testing in a supplement plant says exactly what is being verified, and on what. For a subset of finished batches identified through a sound statistical sampling plan, or for every finished batch, you must verify that the batch meets product specifications for identity, purity, strength, composition, and the limits on those types of contamination that may adulterate or may lead to adulteration of it (111.75(c)). You then select one or more established specifications which, tested on finished batches, would verify that the production and process control system is producing a supplement meeting all product specifications (111.75(c)(1)) — and you may exempt a specification from that verification where you determine and document that no selected specification can verify it and that no scientifically valid method exists to test it at the finished batch stage (111.75(d)(1)). So it is a selection, made by the plant, from specifications the plant wrote.

The rule also fixes what appropriateness is measured against, which is the part worth reading slowly. The tests and examinations you use must be appropriate, scientifically valid methods, and the clause ties both of those words to a stated purpose: to determine whether the specifications are met (111.75(h)(1)). Appropriate to the specification, then. Those tests and examinations must include at least one of the following: gross organoleptic analysis, macroscopic analysis, microscopic analysis, chemical analysis, or other scientifically valid methods (111.75(h)(2); 111.75(h)(2)(i); 111.75(h)(2)(ii); 111.75(h)(2)(iii); 111.75(h)(2)(iv); 111.75(h)(2)(v)).

That is worth saying out loud to whoever runs the testing. A result is an answer to the question that was handed over, and the rule measures the method against that question rather than against the label. Hand over the wrong question and an appropriate, valid method on a representative sample will confirm it, precisely, in writing.

Specimen drawn from our constructed teaching case PROTOCOL Sport, an invented company and product — a release assay that tracked one marker while seven other actives were never assayed

What a supplier’s certificate is evidence of

You are handed a certificate of analysis. It carries a lot number, a method, results and a signature, and it looks like the end of an argument. What it is evidence of is narrower than it looks, and the rule that lets anyone lean on it says so in five conditions.

First, what the certificate route does not cover at all. For a component that is a dietary ingredient, you must conduct at least one appropriate test or examination to verify its identity, unless you petition the agency and the agency exempts you from that testing (111.75(a)(1)(i); 111.75(a)(1)(ii)). Your own test. A supplier’s paper is not one of the options.

The certificate route is for the other components, and it is a choice of route rather than a choice about whether to check. You must confirm the identity of those components and determine whether the other applicable component specifications are met, and to do that you must either conduct appropriate tests or examinations yourself, or rely on a certificate of analysis from the supplier of the component that you receive (111.75(a)(2); 111.75(a)(2)(i); 111.75(a)(2)(ii)). Reliance is conditional, and the conditions are the whole of what makes a certificate worth anything.

• You first qualify the supplier by establishing the reliability of the supplier’s certificate of analysis through confirmation of the results of the supplier’s tests or examinations (111.75(a)(2)(ii)(A)).
• The certificate includes a description of the test or examination methods used, the limits of those tests or examinations, and the actual results (111.75(a)(2)(ii)(B)).
• You maintain documentation of how you qualified the supplier (111.75(a)(2)(ii)(C)), and that documentation is a record the part requires the person subject to it to make and keep (111.95(b)(2)).
• You periodically re-confirm the supplier’s certificate of analysis (111.75(a)(2)(ii)(D)).
• Quality control personnel review and approve the documentation setting out the basis for qualifying and requalifying the supplier (111.75(a)(2)(ii)(E)).

Read the first one again. The reliability of the certificate is established by confirming the results the supplier reported, and the clause does not make the certificate its own confirmation. Where a certificate arrives under an internal product code matching nothing anyone buys, there is no way to say which material those results describe, so nothing on the page has been tied to your material yet.

That is the honest limit of a certificate. It reports on a lot, and the identity of that lot is the thing the clause never asks anyone to check twice, because the code on the page belongs to the supplier and is printed nowhere on your product.

The accuracy test you are measured by is not the one you ran

Say the panel declares 500 mg and you want to know whether that is true. There is a written answer to what true means here, and it is not that a laboratory said so.

Compliance with the Supplement Facts section is determined in accordance with the nutrition-labeling compliance provisions, except that the sample for analysis is a composite of 12 subsamples, meaning consumer packages, or 10 percent of the number of packages in the same inspection lot, whichever is smaller, randomly selected to be representative of the lot (21 CFR 101.36(f)(1)). For a conventional food the composite is 12 subsamples taken one from each of 12 different randomly chosen shipping cases, and unless a particular method is specified the composites are analyzed by appropriate methods given in the Official Methods of Analysis of the AOAC International, or by other reliable and appropriate analytical procedures where no AOAC method is available or appropriate (101.9(g)(2)). Note what just happened. The method benchmark moved off your specification and onto a named external one.

Two classes then decide the acceptance rule. Class I is added nutrients in fortified or fabricated foods; class II is naturally occurring ones, except that where an exogenous source of the same nutrient is also added to the final product, the total amount falls under the class I requirements (101.9(g)(3); 101.9(g)(3)(i); 101.9(g)(3)(ii)). A class I nutrient must be formulated to be at least equal to the value declared on the label (101.9(g)(4)(i)). A class II nutrient’s composite must be at least equal to 80 percent of the declared value, and no regulatory action is based on a value falling below that level by less than the variability generally recognized for the analytical method used (101.9(g)(4)(ii)). Both rules are written for a named set: a vitamin, mineral, protein, total carbohydrate, dietary fiber, soluble fiber, insoluble fiber, or polyunsaturated or monounsaturated fat (101.9(g)(4)). Those same class criteria apply to the other dietary ingredients described in the panel rule, which is where a botanical or an amino acid sits (101.36(f)(1); 101.36(b)(3)(i)). Reasonable excesses over labeled amounts are acceptable within current good manufacturing practice (101.36(f)(1); 101.9(g)(6)).

Be careful with that pair of numbers, because the difference between them is the difference between at least the declared amount and four fifths of it. The rule does not tell you which class your own ingredient is. It tells you the test that decides: whether the nutrient was added to the product or is indigenous to it, and whether an exogenous source was also added on top. Run that against your own formula, or ask whoever wrote the specification, before you read any result as a pass.

For calories, total sugars, added sugars where the clause’s own condition is met, the fats, cholesterol and sodium, the test runs the other way. The food is misbranded if the composite is more than 20 percent in excess of the declared value, subject to the same allowance for analytical variability (101.9(g)(5)). Two alternatives sit alongside all of this: compliance may instead be shown through an FDA approved database computed to the agency’s guideline procedures (101.9(g)(8)), and where compliance is not technologically feasible or is impracticable, FDA may permit alternative means or additional exemptions (101.36(f)(2)).

So the measurement that decides whether a panel is accurate uses a sampling plan nobody in the plant used, drawn from an inspection lot rather than from a release sample, against acceptance rules written in the labeling part rather than in anyone’s specification. A supplier’s certificate and a release assay are both real evidence. Neither of them is this test.

Which check answers which question

Take the question you actually have to the check whose benchmark is written to answer it. The third column is the part that costs money later.

Each row states the question, what answers it and what the rule makes its benchmark, and what that check still leaves open.

The question you actually have	What answers it, and the benchmark the rule gives it	What it still does not answer
Does the finished product meet what was specified?	Finished-batch verification, against selected product specifications for identity, purity, strength, composition and contamination limits (111.75(c); 111.75(c)(1))	Whether the specification held the right number to declare in the first place
Would the agency’s own analysis agree with the panel?	The compliance determination, on a composite drawn from an inspection lot, class I formulated at least equal to the declared value and class II at least 80 percent of it, for the nutrients the clause names (101.36(f)(1); 101.9(g)(4)(i); 101.9(g)(4)(ii))	Anything that is not a declared amount: identity, claims, allergen declarations, placement, type size
Is a supplier’s certificate evidence about my material?	Supplier qualification, by confirmation of the supplier’s reported results, with method, limits and actual results on the certificate and the qualification kept as a record (111.75(a)(2)(ii)(A); 111.75(a)(2)(ii)(B); 111.95(b)(2))	The identity of a component that is a dietary ingredient, which takes a test by the party subject to the part (111.75(a)(1)(i))
Did the label that went on match the one that was approved?	The label examinations before and after the run, against the label specification and the master manufacturing record (111.75(f)(2); 111.75(g); 111.410(c))	Whether the approved label was lawful
May I make this health claim?	The authorization route, benchmarked on significant scientific agreement among qualified experts on the totality of publicly available scientific evidence (101.14(c); 101.14(e))	Every other sentence on the pack. It reaches health claims and nothing else
Is the rest of the wording lawful, and will a marketplace accept the artwork?	No check is defined in these three parts. The requirements are stated and nobody is appointed to read a label against them; a marketplace answer sits in that company’s own policy document	All of it, until someone is appointed and what they are reading it against is written down

Read from the text of each clause named, on August 20, 2026. What this does not evidence: it is a reading of the clauses listed and not a complete list of the checks a product may pass through, nor a complete statement of what any of them requires. It says nothing about state law, about a private standard you may have joined, or about what a particular company demands of you.

The checks no rule defines

An attorney, a consultant, a designer, a printer, a marketplace’s own testing program. We went looking for them properly rather than assuming. Searching the text of every clause in 21 CFR parts 101, 111 and 701, the word attorney appears twice, both times naming who may sign a petition (101.69(j); 101.70(i)). Lawyer, consultant, printer, designer and marketplace do not appear at all. Nothing in those parts defines what any of them must examine, or against what.

Method: a full-text search of the clauses of 21 CFR parts 101, 111 and 701, read on August 20, 2026, then a reading of each hit. What this does not evidence: it is a search of three parts rather than of every authority in the United States, and it is a search for a form of words. A duty could be expressed without using any of them, and nothing here reaches state law, contract law or a private standard.

That absence has one practical consequence, and it is the whole of the answer to whether you can trust whoever does it. Where no rule sets the benchmark, the benchmark is whatever the engagement says it is. So the question that gets you something useful is not about the provider. It is about the document: which one is my label being read against, and what comes back at the end — a list of what fails, or wording that would pass. Those are two different products and they cost different money. If nobody can name the document, ask what the check is being run against before you pay for it.

One case deserves precision, because a real rule sits behind it and the two get blurred. A testing program that flags your type size is applying a size rule that exists. Information on the Supplement Facts panel other than the title, headings and footnotes must be in uniform type no smaller than 8 point, with 6 point permitted for column headings and footnotes, and a separate allowance for small and intermediate sized packages (101.36(e)(4)). Whether a given program applies that rule, a stricter one of its own, or a different one entirely is set in that program’s own document. Ask for it before the sample ships, and read it beside the clause.

What passes every check

A constructed example. The company and the number are invented; the clauses are real and cited.

A panel declares 500 mg of an ingredient per serving. Three checks run on that product, and all three are done properly.

The supplier’s certificate reports the raw material assay, carrying the method, the limits and the actual results (111.75(a)(2)(ii)(B)). Pass. The finished batch is verified against the selected product specifications for identity, purity, strength and composition (111.75(c); 111.75(c)(1)), and the specification says 500 mg. Pass. The finished pack is examined to confirm the specified packaging was used and the specified label applied (111.75(g)), and the specification says 500 mg. Pass.

Three clean results, every one of them true. What they have in common is that the number entered the system once, at the top, and each check confirmed the system is consistent with it. None of the three is the compliance determination in the panel rule, which is made on a composite drawn from an inspection lot rather than on the sample release testing chose, by a method the labeling part names rather than one the specification names (101.36(f)(1); 101.9(g)(2)).

That is what the trust question comes down to. Each of those checks is sound inside its own benchmark and silent outside it. Nothing goes wrong in any one of them. The product goes wrong in the space between two, and that space is nobody’s benchmark.

Which is also what a clean state looks like, and it is worth saying plainly because most of this article is written in the negative. If you can name the document behind every check your product passes through, and the set of those documents covers the panel, the claims and the product as made, then there is no space left between them and you are where you want to be. The gap is not permanent and it is not a fact about your operation. It is a fact about which benchmarks you have written down.

Four things to check before your next print run

The first applies to anyone. The other three assume a dietary supplement made under part 111; if that is not your product, the first one is still the whole method.

• For every check anyone is running on your behalf, get the benchmark in one sentence: which document is my label, or my product, being compared against. Ask it of your maker, your laboratory, your reviewer and any program whose mark goes on the pack.
• Ask your manufacturer which route each component went down, an identity test by the party subject to the part (111.75(a)(1)(i)) or reliance on a supplier’s certificate (111.75(a)(2)(ii)). If it was the second, ask for the qualification documentation the part requires to be kept (111.95(b)(2)), and ask when it was last re-confirmed (111.75(a)(2)(ii)(D)).
• Read the certificates for the product identifier before you read the results. If the code on the certificate is not one your product is bought under, nothing on that page has been tied to your material yet.
• Ask which specifications were selected for finished-batch verification and which were exempted from it (111.75(c)(1); 111.75(d)(1)). An exemption is allowed and has to be documented, and whoever never asks assumes everything on the panel was verified.

If all four come back with a named document, you have the map and the work is keeping it current. If none of the four is yours, because you sell a cosmetic or a conventional food or you buy finished goods and touch nothing, the first question is still the one to ask, and the answer you are looking for is the same: name the document.

Related reading: is my supplement label missing anything FDA requires, which sets out the panel elements and the label-control clauses behind them, and who is supposed to build the label content, you or your manufacturer, which is where the ownership of the words gets settled.